Info

Stocks-in-Depth

The Stocks-in-Depth podcast is provided by GARP Research, a provider of institutional equity research reports since 1995. GARP is renown for the granularity of its models and extensive written assessments of competitive threats and vulnerabilities. GARP's investment philosophy is predicated on discovering opportunity through fundamental assessment via intensive modelling, having a wide ranging curiosity about strategic influences, and engaging in person-to-person contact. GARP looks for long-term growth, but it is cognizant of finding value in contrarian situations and wants valuation to be reasonable relative to potential earnings.
RSS Feed
Stocks-in-Depth
2019
January


2018
December
November
October


2017
October
September
January


2016
December
November
October
July
June
May
April
March
February
January


2015
December
November


All Episodes
Archives
Now displaying: Page 1
SID 0002 Myriad Genetics 0
Nov 2, 2015

In Myriad's analyst day in NYC on September 14, 2015, management discussed the outlook for several new growth drivers, and it addressed challenges faced in its legacy BRCA1/2 hereditary cancer genetic testing franchise.  We explore what's new, the ins and outs of each opportunity, and delve into the intricacies of companion diagnostics.

0 Comments
Adding comments is not available at this time.
©© Gaineswood Investment Management, Inc.